Contec Medical (China) Performance
300869 Stock | 15.65 0.34 2.13% |
On a scale of 0 to 100, Contec Medical holds a performance score of 8. The firm shows a Beta (market volatility) of -0.12, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Contec Medical are expected to decrease at a much lower rate. During the bear market, Contec Medical is likely to outperform the market. Please check Contec Medical's downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Contec Medical's price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Contec Medical Systems are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Contec Medical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0188 | Payout Ratio 0.234 | Forward Dividend Rate 0.3 | Ex Dividend Date 2024-05-29 |
1 | Subdued Growth No Barrier To Contec Medical Systems Co.,Ltds Price - Simply Wall St | 09/30/2024 |
Begin Period Cash Flow | 1.4 B | |
Free Cash Flow | 257.9 M |
Contec |
Contec Medical Relative Risk vs. Return Landscape
If you would invest 1,312 in Contec Medical Systems on September 5, 2024 and sell it today you would earn a total of 287.00 from holding Contec Medical Systems or generate 21.88% return on investment over 90 days. Contec Medical Systems is generating 0.4123% of daily returns and assumes 3.8365% volatility on return distribution over the 90 days horizon. Simply put, 34% of stocks are less volatile than Contec, and 92% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Contec Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Contec Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Contec Medical Systems, and traders can use it to determine the average amount a Contec Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1075
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | 300869 | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.84 actual daily | 34 66% of assets are more volatile |
Expected Return
0.41 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Contec Medical is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Contec Medical by adding it to a well-diversified portfolio.
Contec Medical Fundamentals Growth
Contec Stock prices reflect investors' perceptions of the future prospects and financial health of Contec Medical, and Contec Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Contec Stock performance.
Return On Equity | -0.0097 | ||||
Return On Asset | -0.0102 | ||||
Profit Margin | (0.04) % | ||||
Operating Margin | 0.11 % | ||||
Current Valuation | 6.07 B | ||||
Shares Outstanding | 401.8 M | ||||
Price To Book | 3.32 X | ||||
Price To Sales | 13.56 X | ||||
Revenue | 734.05 M | ||||
Gross Profit | 330 M | ||||
EBITDA | 136.65 M | ||||
Net Income | 165.77 M | ||||
Total Debt | 1.05 B | ||||
Book Value Per Share | 4.81 X | ||||
Cash Flow From Operations | 288.68 M | ||||
Earnings Per Share | (0.05) X | ||||
Total Asset | 3.22 B | ||||
Retained Earnings | 1.09 B | ||||
About Contec Medical Performance
By analyzing Contec Medical's fundamental ratios, stakeholders can gain valuable insights into Contec Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Contec Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Contec Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Contec Medical is entity of China. It is traded as Stock on SHE exchange.Things to note about Contec Medical Systems performance evaluation
Checking the ongoing alerts about Contec Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Contec Medical Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Contec Medical had very high historical volatility over the last 90 days | |
About 63.0% of the company shares are owned by insiders or employees |
- Analyzing Contec Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Contec Medical's stock is overvalued or undervalued compared to its peers.
- Examining Contec Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Contec Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Contec Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Contec Medical's stock. These opinions can provide insight into Contec Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Contec Stock analysis
When running Contec Medical's price analysis, check to measure Contec Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Contec Medical is operating at the current time. Most of Contec Medical's value examination focuses on studying past and present price action to predict the probability of Contec Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Contec Medical's price. Additionally, you may evaluate how the addition of Contec Medical to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |